Gene-environment interactions in wet beriberi: Effects of thiamine depletion in CD36-defect rats

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 285, Issue 4 54-4, 2003, Pages

  Tanaka, Takao ^a   Kono, Tatsuji ^a   Terasaki, Fumio ^a   Kintaka, Taigo ^a   Sohmiya, Koichi ^a   Mishima, Takayuki ^a   Kitaura, Yasushi ^a  

^a OSAKA MEDICAL COLLEGE   (Japan)

Author keywords

CD36 deficiency

Indexed keywords

CD36 ANTIGEN; FATTY ACID; GENOMIC DNA; GLUCOSE; LACTIC ACID; LONG CHAIN FATTY ACID; THIAMINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BERIBERI; BLOOD PH; BODY WEIGHT; CLINICAL FEATURE; CONTROLLED STUDY; DIET THERAPY; DISEASE PREDISPOSITION; DNA DETERMINATION; ENVIRONMENTAL FACTOR; FATTY ACID TRANSPORT; GENETIC SUSCEPTIBILITY; HEART OUTPUT; HEREDITY; HISTOPATHOLOGY; LACTATE BLOOD LEVEL; LACTIC ACIDEMIA; LUNG CONGESTION; LUNG WEIGHT; NONHUMAN; PRIORITY JOURNAL; RAT; RAT STRAIN; SPONTANEOUSLY HYPERTENSIVE RAT; SYSTEMIC VASCULAR RESISTANCE; THIAMINE DEFICIENCY;

EID: 0141676779     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.00182.2003     Document Type: Article

References (41)

1. Aalsmeer WC and Wenckebach KF. The heart and circulatory system in beriberi. Am Heart J 4: 630-631, 1929.
2. Abumurad N, El-Maghrabi M, Amri EZ, Lopez E, and Grimaldi P. Cloning of a rat adipocyte membrane protein implicated in binding or transport of long-chain fatty acids that is induced during preadipocyte differentiation. J Biol Chem 268: 17665-17668, 1993.
3. Aitman TJ, Glazier AM, Wallace CA, Cooper LD, Norsworthy PJ, Wahid FN, Al-Majali KM, Trembling PM, Mann CJ, Shoulders CC, Graf D, St-Lezin E, Kurtz TW, Kren V, Pravenec M, Ibrahimi A, Abumrad NA, Stanton LW, and Scott J. Identification of Cd36 (fat) as an insulin-resistance gene causing defective fatty acid and glucose metabolism in hypertensive rats. Nat Genet 21: 76-83, 1999.
4. Akbarian M, Yankopoulos NA, and Abelmann WH. Hemodynamic studies in beriberi heart disease. Am J Med 41: 197-212, 1966.
5. Bakker SJ and Leunissen KM. Hypothesis on cellular ATP depletion and adenosine release as causes of heart failure and vasodilatation in cardiovascular beriberi. Med Hypotheses 45: 265-267, 1995.
6. Barger PM and Kelly DP. Fatty acid utilization in the hypertrophied and failing heart: molecular regulatory mechanisms. Am J Med Sci 318: 36-42, 1999.
7. Brady JA, Rock CL, and Horneffer MR. Thiamin status, diuretic medications, and the management of congestive heart failure. J Am Diet Assoc 95: 541-544, 1995.
8. Braunwald E, Zipes DP, and Libby P. Heart Disease. Philadelphia, PA: Saunders, 2001.
9. Brinkmann JF, Abumrad NA, Ibrahimi A, van der Vusse GJ, and Glatz JF. New insights in long-chain fatty acid uptake by heart muscle: a crucial role for FAT/CD36. Biochem J 367: 561-570, 2002.
10. Buttrick PM, Kaplan M, Leinwand LA, and Scheuer J. Alterations in gene expression in the rat heart after chronic pathological and physiological loads. J Mol Cell Cardiol 26: 61-67, 1994.
11. Cappelli V, Bottinelli R, Polla B, and Reggiani C. Altered contractile properties of rat cardiac muscle during experimental thiamine deficiency and food deprivation. J Mol Cell Cardiol 22: 1095-1106, 1990.
12. Christe ME and Rodgers RL. Altered glucose and fatty acid oxidation in hearts of the spontaneously hypertensive rat. J Mol Cell Cardiol 26: 1371-1375, 1994.
13. Coburn CT, Knapp FF Jr, Febbraio M, Beets AL, Silverstein RL, and Abumrad NA. Defective uptake and utilization of long chain fatty acids in muscle and adipose tissues of CD36 knockout mice. J Biol Chem 275: 32523-32529, 2000.
14. Fukuchi K, Nozaki S, Yoshizumi T, Hasegawa S, Uehara T, Nakagawa T, Kobayashi T, Tomiyama Y, Yamashita S, Matsuzawa Y, and Nishimura T. Enhanced myocardial glucose use in patients with a deficiency in long-chain fatty acid transport (CD36 deficiency). J Nucl Med 40: 239-243, 1999.
15. Glazier AM, Scott J, and Aitman TJ. Molecular basis of the Cd36 chromosomal deletion underlying SHR defects in insulin action and fatty acid metabolism. Mamm Genome 13: 108-113, 2002.
16. Gotoda T, Iizuka Y, Kato N, Osuga J, Bihoreau MT, Murakami T, Yamori Y, Shimano H, Ishibashi S, and Yamada N. Absence of Cd36 mutation in the original spontaneously hypertensive rats with insulin resistance. Nat Genet 22: 226-228, 1999.
17. Greenwalt DE, Lipsky RH, Ockenhouse CF, Ikeda H, Tandon NN, and Jamieson G. Membrane glycoprotein CD36: a review of its roles in adherence, signal transduction and transfusion medicine. Blood 80: 1105-1115, 1992.
18. Hajri T, Ibrahimi A, Coburn CT, Knapp FF Jr, Kurtz T, Pravenec M, and Abumrad NA. Defective fatty acid uptake in the spontaneously hypertensive rat is a primary determinant of altered glucose metabolism, hyperinsulinemia, and myocardial hypertrophy. J Biol Chem 276: 23661-23666, 2001.
19. Hamilton JA and Kamp F. How are free fatty acids transported in membranes? Is it by proteins or by free diffusion through the lipids? Diabetes 48: 2255-2269, 1999.
20. Kantor PF, Robertson MA, Coe JY, and Lopaschuk GD. Volume overload hypertrophy of the newborn heart slows the maturation of enzymes involved in the regulation of fatty acid metabolism. J Am Coll Cardiol 33: 1724-1734, 1999.
21. Kashiwagi H, Tomiyama Y, Kosugi S, Shiraga M, Lipsky R, Kanayama Y, Kurata Y, and Matsuzawa Y. Identification of molecular defect in a subject with type I CD36 deficiency. Blood 83: 3545-3552, 1994.
22. Kintaka T, Tanaka T, Imai M, Adachi I, Narabayashi I, and Kitaura Y. Genotype of CD36 and long-chain fatty acids uptake in the heart. Circ J 66: 819-825, 2002.
23. Kolm-Litty V, Sauer U, Nerlich A, Lehmann R, and Schleicher ED. High glucose-induced transforming growth factor beta1 production is mediated by the hexosamine pathway in porcine glomerular mesangial cells. J Clin Invest 101: 160-169, 1998.
24. Kusaka Y, Tanaka T, Okamoto F, Terasaki F, Matsunaga Y, Miyazaki H, and Kawamura K. Effect of sulfo-N-succinimidyl palmitate on the rat heart: myocardial long-chain fatty acid uptake and cardiac hypertrophy. J Mol Cell Cardiol 27: 1605-1612, 1995.
25. Lopaschuk GD, Rebeyka IM, and Allard MF. Metabolic modulation: a means to mend a broken heart. Circulation 105: 140-142, 2002.
26. Lydell CP, Chan A, Wambolt RB, Sambandam N, Parsons H, Bondy GP, Rodrigues B, Popov KM, Harris RA, Brownsey RW, and Allard MF. Pyruvate dehydrogenase and the regulation of glucose oxidation in hypertrophied rat hearts. Cardiovasc Res 53: 841-851, 2002.
27. Mall G, Mattfeldt T, Mobius HJ, and Leonhard R. Stereological study on the rat heart in chronic alimentary thiamine deficiency-absence of myocardial changes despite starvation. J Mol Cell Cardiol 18: 635-643, 1986.
28. Manning WJ, Wei JY, Katz SE, Litwin SE, and Douglas PS. In vivo assessment of LV mass in mice using high-frequency cardiac ultrasound: necropsy validation. Am J Physiol Heart Circ Physiol 266: H1672-H1675, 1994.
29. Rieck J, Halkin H, Almog S, Seligman H, Lubetsky A, Olchovsky D, and Ezra D. Urinary loss of thiamine is increased by low doses of furosemide in healthy volunteers. J Lab Clin Med 134: 238-243, 1999.
30. Scriba K. Uber die Morphologie der Herzmuskulatur bei Experimentaller Beriberi. Verh Dtsch Ges Pathol 31: 343-347, 1983.
31. Singleton CK and Martin PR. Molecular mechanisms of thiamine utilization. Curr Mol Med 1: 197-207, 2001.
32. Slama M, Susic D, Varagic J, Ahn J, and Frohlich ED. Echocardiographic measurement of cardiac output in rats. Am J Physiol Heart Circ Physiol 284: H691-H697, 2003.
33. Smith SW. Severe acidosis and hyperdynamic circulation in a 39-year-old alcoholic. J Emerg Med 16: 587-591, 1998.
34. 1: are diuretics a risk factor for thiamin malnutrition? Nutr Rev 58: 319-323, 2000.
35. Tanaka T, Nakata T, Oka T, Ogawa T, Okamoto F, Kusaka Y, Sohmiya K, Shimamoto K, and Itakura K. Defect in human myocardial long-chain fatty acid uptake is caused by FAT/CD36 mutations. J Lipid Res 42: 751-759, 2001.
36. Tanaka T, Okamoto F, Sohmiya K, and Kawamura K. Lack of myocardial iodine-123 15-(p-iodiphenyl)-3-R,S-methylpentadecanoic acid (BMIPP) uptake and CD36 abnormality-CD36 deficiency and hypertrophic cardiomyopathy. Jpn Circ J 61: 724-725, 1997.
37. Tanaka T, Sohmiya K, and Kawamura K. Is CD36 deficiency an etiology of hereditary hypertrophic cardiomyopathy? J Mol Cell Cardiol 29: 121-127, 1997.
38. Togay-Isikay C, Yigit A, and Mutluer N. Wernicke's encephalopathy due to hyperemesis gravidarum: an under-recognised condition. Aust NZ J Obstet Gynaecol 41: 453-456, 2001.
39. Wohl MG, Shuman CR, Turner R, and Fittipoldi JJJ. Thiamine deficiency in organic heart disease. Circulation 8: 744-749, 1953.
40. Young ME, McNulty P, and Taegtmeyer H. Adaptation and maladaptation of the heart in diabetes. Part II: potential mechanisms. Circulation 105: 1861-1870, 2002.
41. Yui Y, Itokawa Y, and Kawai C. Furosemide-induced thiamine deficiency. Cardiovasc Res 14: 537-540, 1980.